MNDL Bio

Proud to see MNDL Bio on the FoodTech 500 list! 🌍✨ Exciting times ahead for gene optimization and biotech innovation! 🧬🔝

Glad to be a portfolio company of Earth & Beyond Ventures!

Proud of our team! Major milestone for MNDL Bio! 🎉

We are proud to be part of Earth & Beyond Ventures' Portfolio

5 leading AI trends and startups to watch in 2025. From cybersecurity to biotech, local ventures excel in applicative and vertical AI, driving global industry transformation. Cynomi Qodo (formerly Codium) NeoLogic MNDL Bio Nimble

We are deeply honored and humbled to be recognized among Israel's top AI trends and promising startups to watch in 2025 by CTech by Calcalist's VC Survey. As Tal Brody once famously declared, "We are on the map! And we are staying on the map - not only in sports, but in everything." Today, we're proud to be part of that "everything" - representing Israel's growing prominence in AI-powered biotechnology. At MNDL Bio, we're committed to transforming the biotech landscape through our AI platform, making protein production more efficient and accessible. Steve Grün Eran Miller Tamir Tuller Guy Bushkin Maoz Gelbart Sella Rafaeli 🇮🇱🇺🇸 We're honored to be featured alongside Cynomi, Qodo (formerly Codium), NeoLogic, and Nimble . Thank you to Earth & Beyond Ventures, the Israel Innovation Authority רשות החדשנות, CPT Capital and the VC community for believing in our vision. This is just the beginning of our journey to make synthetic biology solutions more accessible and impactful for companies worldwide. #IsraeliTech #AI #Biotech #Innovation #SyntheticBiology #StartUpNation Link to CTech article in first comment

Last seats available! Join us tomorrow in a ScienceAbroad webinar: Unlocking the potential of #RecombinantProteins - MNDL Bio's online end-to-end gene optimization solutions Recombinant protein production has revolutionized various industries, but it often faces significant challenges in terms of scale-up - yield and cost. MNDL Bio's innovative gene optimization technology, based on 15 years of R&D and hundreds of models and algorithms, addresses these challenges by re-engineering gene sequences. In this presentation, we will discuss: - The challenges associated with recombinant protein expression - Unique approaches to gene optimization - Case studies demonstrating the effectiveness of our technology - The potential applications This presentation should interest anyone who: - Performs research in biotechnology or synthetic biology - Is involved in recombinant protein production, whether in research, pharma, food, or industrial applications. - Faces challenges with low yields, high costs, or inconsistent quality in protein production. - Wants to stay updated on advancements in gene optimization technologies. About the speaker: Dr. Guy Bushkin, MNDL Bio's Product and Synthetic Biology Director Guy has PhD in Microbiology and Molecular Biology, he is an expertise in low and high-throughput protein expression workflows using diverse hosts including yeast, bacteria, mammalian cells, and cell-free systems. Ministry of Aliyah and Integration משרד העלייה והקליטה https://lnkd.in/eHvDNGjh Steve Grün Tamir Tuller Eran Miller Guy Bushkin Maoz Gelbart Sella Rafaeli 🇮🇱🇺🇸 Thanks for inviting us! Dana Berenson, ScienceAbroad

Our co-founder & CEO Steve Grün is proud to speak at #CollerTalks (Jan 20th), sharing MNDL Bio's journey in revolutionizing recombinant protein production through gene optimization. 🧬 Join to explore the future of #AnimalsFree tech and learn about the #CollerStartupCompetition's $100K investment opportunity. Register: https://lnkd.in/d2UPY53m #Biotech #Innovation #Sustainability

🧬 Excited to share MNDL Bio's entrepreneurial journey at the upcoming Coller Startup Competition Alumni event! Tamir Tuller Eran Miller 🚀 As we transform the biotechnology landscape with our AI-powered gene expression optimization platform, we're helping companies achieve unprecedented protein production yields while significantly accelerating development timelines. 💪 I'll be joined by other amazing founders who started at Coller: 🔬 WISP (formerly Mybouncer) (real-time substance safety), 📈 Journeyz (AI for B2B SaaS), ❤️ Symbiosis C.M. (innovative heart valve solutions), 🍬 Sweet Victory Gum (sugar-craving control gum), and 🧠 Xtrodes (revolutionary sleep & cardiac monitoring). From winning startup pitches to building impactful companies - come hear our stories and insights on January 20th at Tel Aviv University! Learn how we turned our ideas into reality and what we learned along the way. ✨ Earth & Beyond Ventures CPT Capital Harry Kalms Daniel Recanati Israel Biran Doron Zauer Zack Fagan Noga Yaari Lior Harel Assaf Wise Guy Bushkin Maoz Gelbart Sella Rafaeli 🇮🇱🇺🇸 Dan Launchpad (TAU Startup Program) MassChallenge Israel Hello Tomorrow EIT Food #Biotechnology #Innovation #StartupJourney #Collerstartupcompetition #TelAviv #TAU

Webinar: Unlocking the potential of recombinant proteins - MNDL Bio's online end-to-end gene optimization solutions. Recombinant protein production has revolutionized various industries, but it often faces significant challenges in terms of yield, quality, and cost. MNDL Bio's innovative gene optimization technology, based on 15 years of R&D and hundreds of models and algorithms, addresses these challenges by precisely tailoring gene sequences to enhance protein expression in a variety of host organisms. In this presentation, we will discuss: The challenges associated with recombinant protein expression Unique approaches to gene optimization Case studies demonstrating the effectiveness of our technology The potential applications This presentation should interest anyone who: Performs research in biotechnology or synthetic biology Is involved in recombinant protein production, whether in academia, pharmaceuticals, food, or industrial applications. Faces challenges with low yields, high costs, or inconsistent quality in protein production. Wants to stay updated on advancements in gene optimization technologies. About the speaker: Dr. Guy Bushkin, MNDL Bio's product and synthetic biology director. He has PhD in Microbiology and Molecular Biology from Boston University a postdoc at the Whitehead Institute. Expertise in low and high-throughput protein expression workflows using diverse hosts including yeast, bacteria, mammalian cells, and cell-free systems. *נרשמים יקבלו מייל עם קישור לזום הפעילות ממומנת ע”י משרד העלייה והקליטה – המרכז לקליטה במדע ואגף יזמות עסקית. https://lnkd.in/eHvDNGjh Steve Grün Tamir Tuller Eran Miller הפעילות ממומנת ע”י משרד העלייה והקליטה – המרכז לקליטה במדע ואגף יזמות עסקית Dana Berenson Ministry of Aliyah and Integration משרד העלייה והקליטה